Oncology and Hematology
Episodes 49-64 of 92
Sagar Lonial, MD, FACP
- MinuteCE®
The Evolving Treatment Paradigm for RRMM: The Role of Bispecific Antibodies
1.00 program creditSagar Lonial, MD, FACP
Caitlin Costello, MD
Sagar Lonial, MD, FACP
Caitlin Costello, MD
Sagar Lonial, MD, FACP
Caitlin Costello, MD
Sagar Lonial, MD, FACP
Caitlin Costello, MD
Sagar Lonial, MD, FACP
Caitlin Costello, MD
Sagar Lonial, MD, FACP
Caitlin Costello, MD
Kristen Ciombor, MD
James J. Harding, MD
Filippo Pietrantonio, MD
Kanwal Raghav, MD
Kathleen Moore, MD, MS, FASCO
Brad McGregor, MD
- MinuteCE®
Cervical Cancer: HER2-Targeted ADCs – Current Status and Future Directions
1.00 program creditKathleen Moore, MD, MS, FASCO
Kathleen Moore, MD, MS, FASCO
Brad McGregor, MD
Kathleen Moore, MD, MS, FASCO
Susana Banerjee, MBBS, MA, FRCP, PhD
Brad McGregor, MD
Kathleen Moore, MD, MS, FASCO
Shubham Pant, MD, MBBS
Susana Banerjee, MBBS, MA, FRCP, PhD
